Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 7;105(1):176-180.
doi: 10.4269/ajtmh.20-1330.

Mortality in Parenchymal and Subarachnoid Neurocysticercosis

Affiliations

Mortality in Parenchymal and Subarachnoid Neurocysticercosis

Jesus Abanto et al. Am J Trop Med Hyg. .

Abstract

Neurocysticercosis (NCC) is endemic in many parts of the world, carrying significant neurological morbidity that varies according to whether lesions are located inside the cerebral parenchyma or in extraparenchymal spaces. The latter, in particular subarachnoid NCC, is assumed to be more severe, but no controlled studies comparing mortality between types of NCC exist. The aim of this study was to compare all-cause mortality between patients with intraparenchymal NCC and those with subarachnoid NCC. Vital status and sociodemographic characteristics were evaluated in patients with intraparenchymal viable, intraparenchymal calcified, and subarachnoid NCC attending a neurological referral hospital in Lima, Perú. Survival analyses using Kaplan-Meier curves and Cox proportional regression models were carried out to compare mortality rates between groups. From 840 NCC patients followed by a median time of 82.3 months, 42 (5.0%) died, six (1.8%) in the intraparenchymal viable group, four (1.3%) in the calcified group, and 32 (16.6%) in the subarachnoid group (P < 0.001). Older age and lower education were significantly associated with mortality. The age-adjusted hazard ratio for death in the subarachnoid group was 13.6 (95% CI: 5.6-33.0, P < 0.001) compared with the intraparenchymal viable group and 10.7 (95% CI: 3.7-30.8, P < 0.001) when compared with the calcified group. We concluded that subarachnoid disease is associated with a much higher mortality in NCC.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Probability of survival in patients with intraparenchymal viable, calcified, and subarachnoid Neurocysticercosis. This figure appears in color at www.ajtmh.org.

Similar articles

Cited by

References

    1. Garcia HH, Nash TE, Del Brutto OH, 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202–1215. - PMC - PubMed
    1. Fabiani S, Bruschi F, 2013. Neurocysticercosis in Europe: still a public health concern not only for imported cases. Acta Trop 128: 18–26. - PubMed
    1. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VCW, Pinner RW; EMERGEncy ID NET Study Group , 2002. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8: 608–613. - PMC - PubMed
    1. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T, 2011. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 9: 123–133. - PubMed
    1. Garcia HH, Gonzalez AE, Gilman RH, 2020. Taenia solium cysticercosis and its impact in neurological disease. Clin Microbiol Rev 33: e00085-19. - PMC - PubMed

Publication types

LinkOut - more resources